Sanofi, 10% Owner at REGENERON PHARMACEUTICALS, INC. (REGN), sold 4,799,104 shares at $509.85 ($2.4B) on 2020-05-29, disclosed to the SEC on 2020-05-29.
Open-market sale of $2446.8M REGN by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $509.85 | 2,399,552 | $1.2B | 50.0% |
| 2 | $509.85 | 2,399,552 | $1.2B | 50.0% |
| Total | $509.85 avg | 4,799,104 | $2.4B | 100% |
| Filing → |
| ICVX | BUY | 2021-08-02 | $1.0M | — | Filing → |
| INZY | BUY | 2020-07-29 | $1.3M | — | Filing → |
| REGN | SELL | 2020-06-11 | $143.7M | — | Filing → |